Clinically isolated syndromes and the relationship to multiple sclerosis

被引:43
作者
Brownlee, Wallace J. [1 ]
Miller, David H. [1 ,2 ]
机构
[1] UCL Inst Neurol, Queen Sq Multiple Sclerosis Ctr, Dept Neuroinflammat, London, England
[2] NIHR Univ Coll London Hosp, Biomed Res Ctr, London, England
关键词
Clinically isolated syndrome; Demyelinating disease; Multiple sclerosis; Optic neuritis; SPINAL-CORD LESIONS; OPTIC NEURITIS; FOLLOW-UP; DIAGNOSTIC-CRITERIA; COGNITIVE IMPAIRMENT; DEMYELINATING EVENT; INTERFERON BETA-1A; PREDICTIVE-VALUE; MRI CRITERIA; BRAIN-STEM;
D O I
10.1016/j.jocn.2014.02.026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The most common presentation of multiple sclerosis (MS) is with a clinically isolated syndrome (CIS) affecting the optic nerves, brainstem or spinal cord. Two thirds of patients with CIS will have further episodes of neurological dysfunction and convert to relapsing-remitting MS, while the remaining patients have a monophasic illness, at least clinically. Abnormalities on a baseline MRI scan predict the subsequent development of MS in patients with CIS. In the long term, about 80% of patients with an abnormal MRI convert to MS compared with 20% with a normal MRI. For patients who develop MS the long term prognosis is varied. After 20 years, almost half will have developed secondary progressive MS, while around one third have a benign disease course with little physical disability. Disease-modifying treatments delay conversion to MS in selected CIS patients with abnormal MRI but an effect on long term disability has not been demonstrated. In this review we discuss recent advances in the diagnosis, management and prognostication of patients with CIS. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2065 / 2071
页数:7
相关论文
共 69 条
  • [1] Optic neuritis
    Balcer, LJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) : 1273 - 1280
  • [2] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
    Barkhof, F
    Filippi, M
    Miller, DH
    Scheltens, P
    Campi, A
    Polman, CH
    Comi, G
    Ader, HJ
    Losseff, N
    Valk, J
    [J]. BRAIN, 1997, 120 : 2059 - 2069
  • [3] Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944
  • [4] A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS
    BECK, RW
    CLEARY, PA
    ANDERSON, MM
    KELTNER, JL
    SHULTS, WT
    KAUFMAN, DI
    BUCKLEY, EG
    CORBETT, JJ
    KUPERSMITH, MJ
    MILLER, NR
    SAVINO, PJ
    GUY, JR
    TROBE, JD
    MCCRARY, JA
    SMITH, CH
    CHROUSOS, GA
    THOMPSON, HS
    KATZ, BJ
    BRODSKY, MC
    GOODWIN, JA
    ATWELL, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) : 581 - 588
  • [5] Brettschneider J, 2006, MULT SCLER, V12, P143
  • [6] The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
    Brettschneider, Johannes
    Czerwoniak, Anne
    Senel, Makbule
    Fang, Lubin
    Kassubek, Jan
    Pinkhardt, Elmar
    Lauda, Florian
    Kapfer, Tamara
    Jesse, Sarah
    Lehmensiek, Vera
    Ludolph, Albert C.
    Otto, Markus
    Tumani, Hayrettin
    [J]. PLOS ONE, 2010, 5 (08):
  • [7] Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727
  • [8] The predictive value of gray matter atrophy in clinically isolated syndromes
    Calabrese, M.
    Rinaldi, F.
    Mattisi, I.
    Bernardi, V.
    Favaretto, A.
    Perini, P.
    Gallo, P.
    [J]. NEUROLOGY, 2011, 77 (03) : 257 - 263
  • [9] Role of MRI in the differentiation of ADEM from MS in children
    Callen, D. J. A.
    Shroff, M. M.
    Branson, H. M.
    Li, D. K.
    Lotze, T.
    Stephens, D.
    Banwell, B. L.
    [J]. NEUROLOGY, 2009, 72 (11) : 968 - 973
  • [10] MRI only conversion to multiple sclerosis following a clinically isolated syndrome
    Chard, D. T.
    Dalton, C. M.
    Swanton, J.
    Fisniku, L. K.
    Miszkiel, K. A.
    Thompson, A. J.
    Plant, G. T.
    Miller, D. H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (02) : 176 - 179